Potassium Abnormalities Up 1-Year Mortality in Hospitalized Patients
In a study of hospitalized patients, hypokalemia and hyperkalemia at admission were associated with an increased 1-year mortality risk.
Hyperkalemia
SZC Corrects, Maintains Potassium in Diverse Populations
Sodium zirconium cyclosilicate produced dose-dependent reductions in serum potassium in an international cohort of hyperkalemic outpatients.
Dyskalemia at ICU Admission Ups Cardiac Event, Death Risks
Failure to correct dyskalemia within 2 days increased 28-day mortality risk.
Rapid Hyperkalemia Correction in the Emergency Department May Cut Death Risk
In a study, emergency department patients who experienced serum potassium normalization within 3 to 8 hours had half the death risk of those with persistent hyperkalemia.
Patiromer Effective Up to 1 Year in Advanced Diabetic Kidney Disease
In a 52-week study, daily treatment with patiromer maintained normokalemia in patients, regardless of age.
Reducing RAASi Dose Found to Raise MACE, Death Risk in CKD, Heart Failure
In a study, CKD patients receiving less than half of a guideline-recommended dose of RAASi had a nearly 6-fold higher risk for death and 2-fold higher risk for MACE than patients receiving 50% or more of the recommended dose.
Monthly Blood Testing in the Hemodialysis Population Questioned
In a study, monthly blood testing vs testing every 6 weeks was not associated with a lower risk of death among prevalent and incident hemodialysis (HD) patients, but is associated with an increased risk of hyperkalemia, cardiovascular events, and all-cause hospitalization among incident HD patients.
Hyperkalemia Drug Safe for Use in Adolescent CKD Patients
Preliminary data show that treatment with patiromer is well tolerated and results in clinically meaningful decreases in serum potassium.
Hyperkalemia Excursions May Better Predict Death Risk in Hemodialysis
In a study of hemodialysis patients, the more hyperkalemia excursions, the higher the risk for short-term mortality.
Hyperkalemia Impairs Quality of Life in CKD, Dialysis
KDQOL and EuroQol-5D-3L responses show worse quality of life among kidney disease patients who develop hyperkalemia.
Next post in Hyperkalemia
